Clinical Trial

Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this investigation is to examine NADPH oxidase as a source of reactive oxygen species contributing to aberrant microvascular function in otherwise healthy women with a history of GDM.
Protocol Amendment History 2 changes
critical Enrollment closed, study ongoing 2026-07-30
notable Primary completion moved earlier: 2027-06-30 -> 2026-06-30 2026-07-30
Trial Details
NCT Number NCT05946798
Lead Sponsor Anna Stanhewicz, PhD
Conditions Gestational Diabetes, Oxidative Stress, Vascular Endothelial Function
Enrollment 40 participants
Start Date 2023-08-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-29